<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03969992</url>
  </required_header>
  <id_info>
    <org_study_id>APC-AF-CLN-002</org_study_id>
    <nct_id>NCT03969992</nct_id>
  </id_info>
  <brief_title>A Dose-Ranging Study to Determine the Efficacy, Safety and Tolerability of AeroFact</brief_title>
  <official_title>A Partially Blinded, Randomized, Controlled, Parallel-Group, Dose-Ranging Study to Determine the Efficacy, Safety and Tolerability of AeroFact in Preterm Infants at Risk of Worsening Respiratory Distress Syndrome</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Aerogen Pharma Limited</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Aerogen Pharma Limited</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>Yes</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this two-part Phase 2 study is to assess the safety, tolerability and efficacy
      of aerosolized SF-RI 1 (AeroFact) when delivered via nCPAP at two different doses.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Part I Primary Objective To determine an optimal dose of AeroFact administered by nasal
      continuous positive airway pressure (nCPAP) versus stand of care in reducing the rate of
      intubation/cannulation and bolus surfactant instillation in the first 7 days after birth.

      Part II Primary Objective To evaluate pulmonary outcomes and respiratory utilization at 3, 6,
      9, and 12 months post-menstrual age (PMA)
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">March 4, 2020</start_date>
  <completion_date type="Anticipated">December 30, 2021</completion_date>
  <primary_completion_date type="Anticipated">December 1, 2020</primary_completion_date>
  <phase>Phase 2</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <intervention_model_description>Partially Blinded, Randomized, Parallel-Group Dose Ranging</intervention_model_description>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)</masking>
    <masking_description>Masking within active arms</masking_description>
  </study_design_info>
  <primary_outcome>
    <measure>Incidence of intubation/cannulation and instilled surfactant</measure>
    <time_frame>7 days</time_frame>
    <description>Number of patients who require intubation/cannulation with bolus surfactant instillation</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Percent of patients with respiratory symptoms requiring intervention across groups</measure>
    <time_frame>12 months</time_frame>
    <description>Comparison of respiratory symptoms (Asthma/URI) and respiratory medications between groups</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Percent of patients requiring supplemental oxygen and visits for medical care (Doctor's office/ER/Hospitalization)</measure>
    <time_frame>12 months</time_frame>
    <description>Assess need for supplemental oxygen and other respiratory support and visits to physician office/ER/hospitalizations between groups</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Percent of patients requiring repeat surfactant dosing between groups</measure>
    <time_frame>7 days</time_frame>
    <description>Assess the need for more than one dose of surfactant between groups</description>
  </secondary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Anticipated">261</enrollment>
  <condition>Respiratory Distress Syndrome in Premature Infant</condition>
  <arm_group>
    <arm_group_label>nCPAP alone</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>Standard of Care (nasal continuous positive airway pressure-nCPAP) with instilled bolus surfactant when medically necessary</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Drug: Low Dose AeroFact</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>AeroFact-low dose SF-RI 1</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Drug: High Dose AeroFact</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>AeroFact-high dose SF-RI 1</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>AeroFact</intervention_name>
    <description>Aerosolized SF-RI 1</description>
    <arm_group_label>Drug: High Dose AeroFact</arm_group_label>
    <arm_group_label>Drug: Low Dose AeroFact</arm_group_label>
    <other_name>SF-RI 1</other_name>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>nCPAP</intervention_name>
    <description>nCPAP (nasal continuous positive airway pressure) alone</description>
    <arm_group_label>nCPAP alone</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. Parental consent obtained prior to study procedures being performed (pre-natal consent
             is allowed)

          2. 26 0/7 to 30 6/7 weeks of gestational age

          3. Weight &lt;2.0 Kg

          4. Respiratory Severity Score (RSS) &gt; 1.5

        Exclusion Criteria:

          1. Apgar score less than or equal to 5 at five minutes after birth

          2. Need for chest compressions or administration of epinephrine or bicarbonate in the
             delivery room

          3. Premature rupture of membranes (PROM) &gt; 7 days, or known sepsis with PROM prior to 7
             days

          4. Need for intubation and/or mechanical ventilation prior to enrollment

          5. Active pneumothorax requiring chest tube

          6. Significant congenital anomaly, chromosomal abnormality

          7. Concomitant treatments with inhaled nitric oxide
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>26 Weeks</minimum_age>
    <maximum_age>31 Weeks</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Andy Clark, PhD</last_name>
    <role>Study Director</role>
    <affiliation>Aerogen Pharma Corp</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Judy Doto, RN, BSN</last_name>
    <phone>484-716-5438</phone>
    <email>judydoto@aerogenpharma.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Jeanette Asselin, MS</last_name>
    <phone>510-813-1177</phone>
    <email>jasselin@aerogenpharma.com</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>University of Arkansas for Medical Sciences</name>
      <address>
        <city>Little Rock</city>
        <state>Arkansas</state>
        <zip>72205</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Denise Pearson</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Children's Hospital of Orange County (CHOC)</name>
      <address>
        <city>Orange</city>
        <state>California</state>
        <zip>92868</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Ofelia Vargas-Shiraishi</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Northside Hospital Atlanta</name>
      <address>
        <city>Atlanta</city>
        <state>Georgia</state>
        <zip>30042</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Katrina Grier, RN, BSN</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Hospital of South Bend</name>
      <address>
        <city>South Bend</city>
        <state>Indiana</state>
        <zip>46601</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Mashelle Monhaut, RN, NNP</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Beth Israel Deaconess Medical Center</name>
      <address>
        <city>Boston</city>
        <state>Massachusetts</state>
        <zip>02215</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Neha Talele</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Children's and Women's (C &amp; W) Mott Hospital</name>
      <address>
        <city>Ann Arbor</city>
        <state>Michigan</state>
        <zip>48109</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Diane White, RRT</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Children's Health Care d/b/a Children's Minnesota</name>
      <address>
        <city>Minneapolis</city>
        <state>Minnesota</state>
        <zip>55404</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Cathy Worwa, RRT</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>University of Minnesota Masonic Children's Hospital</name>
      <address>
        <city>Minneapolis</city>
        <state>Minnesota</state>
        <zip>55454</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Jensina Erickson</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>West Chester Medical Center-Maria Fareri Children's Hospital</name>
      <address>
        <city>Valhalla</city>
        <state>New York</state>
        <zip>10595</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Clare Giblin, RN, BSN</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Texas Health-Methodist Harris</name>
      <address>
        <city>Fort Worth</city>
        <state>Texas</state>
        <zip>76104</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Tamara Plant, RN, BSN</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Children's Hospital of San Antonio (CHofSA)</name>
      <address>
        <city>San Antonio</city>
        <state>Texas</state>
        <zip>78207</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Katy Kohlleppel, RN, BSN</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Methodist Children's Hospital</name>
      <address>
        <city>San Antonio</city>
        <state>Texas</state>
        <zip>78229</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Katy Kohlleppel, RN, BSN</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>North Central Baptist Hospital</name>
      <address>
        <city>San Antonio</city>
        <state>Texas</state>
        <zip>78258</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Melanie Drummond, RN, BSN</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>University of Virginia</name>
      <address>
        <city>Charlottesville</city>
        <state>Virginia</state>
        <zip>22947</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Monika Thielen</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>University of Washington</name>
      <address>
        <city>Seattle</city>
        <state>Washington</state>
        <zip>98195</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Elaine Eldridge</last_name>
    </contact>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>July 2020</verification_date>
  <study_first_submitted>April 5, 2019</study_first_submitted>
  <study_first_submitted_qc>May 30, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">May 31, 2019</study_first_posted>
  <last_update_submitted>July 7, 2020</last_update_submitted>
  <last_update_submitted_qc>July 7, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">July 8, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Respiratory Distress Syndrome</keyword>
  <keyword>BPD</keyword>
  <keyword>surfactant</keyword>
  <keyword>Preterm Infant</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Respiratory Distress Syndrome, Newborn</mesh_term>
    <mesh_term>Respiratory Distress Syndrome, Adult</mesh_term>
    <mesh_term>Syndrome</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

